RxDoctor Payments Data

Gabriela Velazquez Ramirez, MD

Vascular Surgery · Winston Salem, NCNPI 1164600284

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. W. L. Gore & Associates, Inc. accounts for 71.7% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $27,481, more than ten times the $84 reported in 2019.

$33,704in general payments, 2019–2025

Across 70 payments — averaging $481.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$24K
  • Penumbra, Inc.$8K
  • Medtronic$439
  • Cook Medical LLC$398
  • Silk Road Medical, Inc.$128
  • KCI USA, Inc.$84
  • plus $80 from 2 others

What the payments were for

  • Consulting fees$19,21057%
  • Speaking & faculty fees$2,4007%
  • Travel & lodging$9,06127%
  • Food & beverage$3,0329%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,704 in reported general payments places this provider in the 85th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$125,455
Medicare patients
487
Services billed
722

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$6,272
Dabigatran EtexilateDabigatran Etexilate Mesylate11$1,797
ClopidogrelClopidogrel Bisulfate49$529
Atorvastatin Calcium15$204
Cilostazol21$167
Rosuvastatin Calcium15$102

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →